Caladan Bio is building the next generation of biomanufacturing technology, starting with high-throughput 250 mL benchtop bioreactors. Our customers use biology to create groundbreaking products—from alternative proteins to high-performance enzymes, sustainable materials, and next-gen therapeutics. Caladan Bio provides fully-automated bioprocessing technology that helps these companies bring products to market faster and more efficiently, from lab scale to production.
| Website | https://caladan.bio |
| Employees | 21 (18 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Cell Culture, Bioreactor Systems, Fermentation, Cell Cultivation, Bioprocessing, Biotechnology, Single Use Bioreactors, Microbial Cultivation, Mammalian Cell Culture, Process Development, Biopharmaceutical Manufacturing, Cell Line Development, Upstream Processing, Downstream Processing, Pharmaceutical Manufacturing, Bioreactor Technology, Laboratory Equipment |
| Competitors | Roche, AbbVie, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Moderna Therapeutics, Lilly India +35 more (view full list) |
Looking for a particular Caladan Bio employee's phone or email?
Michael Kobida is the CEO and Co-Founder of Caladan Bio.
18 people are employed at Caladan Bio.